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Background: Although pulmonary arterial hypertension (PAH) is a potential co-morbidity in
cystic fibrosis (CF), right heart catheterization (RHC) is not commonly performed in this patient
population until referral for lung transplantation.
Material and methods: An non-randomized observational pilot study was performed after an
exercise protocol with an upright stationary bicycle was added to RHC performed in patients
with CF undergoing evaluation for lung transplantation (LT).
Results: Twelve consecutive patients with advanced lung disease due to CF referred for LT
completed RHC with exercise protocol. Transthoracic echocardiography (TTE) prior to the RHC
did not identify evidence of PAH or significant structural abnormalities; right and left ventricular
systolic function were normal. non-randomized RHC in this same cohort found 75% (9/12) had
PAH with an elevation of the mean pulmonary artery pressure (PAP) at rest with a mean (SD)
of 27.8  4.9 mmHg that significantly increased during exercise to 47.2  5.4 mmHg,
pZ 0.0025. For the last 6 patients, pulmonary vascular resistancewas calculated during exercise,
with a significant increase from 3.15 0.3 to 12.8 0.6 Wood Units (pZ 0.0313) comparing mea-
surements at rest to exercise.
Conclusion: RHC at rest and during exercisewas safely and effectively performed in patients with
CF referred for LT. Furthermore, central hemodynamic measurements found significant wors-
ening of PAH during exercise in a small cohort of CF patients with advanced lung disease.
ª 2013 Elsevier Ltd. All rights reserved.722 3425; fax: þ1 614 722 3426.
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1366 D. Hayes et al.IntroductionThe pathophysiology of pulmonary arterial hypertension
(PAH) is complex and not completely understood due to
multiple molecular mechanisms involved. Additionally,
PAH occurs as a primary disorder or as a result of lung
disease. The current diagnostic guidelines for PAH are
based on hemodynamic measurements of right heart
catheterization (RHC) performed at rest, (mean pulmo-
nary arterial pressure (PAP) > 25 mmHg), no pulmonary
venous hypertension with a concomitant pulmonary
capillary wedge pressure (PCWP)  15 mmHg, and a pul-
monary vascular resistance (PVR) > 3 Wood Units [1]. A
mean PAP > 30 mmHg during exercise was previously a
component of the diagnosis of PAH, but this was abolished
due to cutoff value of 30 mmHg being arbitrarily chosen
and not supported by published data [2]. More recently,
exercise-induced PAH was established as a potential
spectrum of PAH, but this is currently undergoing debate
whether it is clinically significant or a normal variant
without clinical significance [3]. Patients with exercise-
induced PAH can be asymptomatic [4,5], while others
have exertional intolerance [6e10]. Some experts
describe exercise-induced PAH as an early and even
potentially treatable phase of PAH at rest, while others
suggest that it is a stable variation of PAH [11e13]. With
limited research in this area, the clinical significance of
exercise-induced PAH remains unclear.
Due to progressive airway obstruction and chronic
hypoxia, patients with cystic fibrosis (CF) are at risk for
the development of PAH. A recent study demonstrated
that mild PAH worsens survival for patients with CF [14].
However, a limiting factor in the clinical care of the
population with CF is that transthoracic echocardiography
(TTE) is used much more commonly in the evaluation for
PAH than RHC due to the invasiveness of catheter place-
ment. However, we hypothesized TTE is poor for the
evaluation of PAH in patients with CF referred for lung
transplantation and further hypothesized these patients
with advanced lung disease can perform exercise during
RHC.Figure 1 Adult patient with cystic fibrosis performing exer-
cise on an recumbent stationary bicycle during right heart
catheterization with catheter in the right internal jugular vein.Methods
Study design and setting
This non-randomized observational pilot study was
approved by the Institutional Review Board at Nationwide
Children’s Hospital and The Ohio State University. An ex-
ercise protocol was added to the RHC for all patients with
CF referred for lung transplantation where measurements
were done at rest and during exercise. Initially, PVR cal-
culations were obtained only at rest, but modifications to
the RHC exercise protocol added PVR measurements dur-
ing exercise for the latter half of the cohort. The elec-
tronic medical record was reviewed for pertinent data
including demographics, body mass index, pulmonary
function measurements, TTE reports, and RHC measure-
ments. The primary outcome was RHC measurements
compared to TTE.Study population
All CF patients referred for lung transplantation between
January 1, 2011 and June 30, 2012 were included in the
study. The diagnosis of CF was based on an abnormal sweat
chloride test or cystic fibrosis transmembrane regulator
(CFTR) genotype [15].
Echocardiography and heart catheterization
The RHC was standardized for the entire cohort with access
via the right internal jugular vein with advancement of the
catheter to the pulmonary artery wedge position under
fluoroscopic guidance. There was continuous monitoring of
PAP at rest and during exercise on an recumbent stationary
bicycle (Fig. 1). Prior to starting the exercise component,
transducer position was recalibrated to the baseline level.
For example, if the mean PAP was 22 mmHg at baseline at
rest, the transducer was recalibrated to the appropriate
position on the bicycle to a mean of 22 mmHg and then the
procedure continued. The pulmonary capillary wedge
pressure (PCWP) was recorded at the end of exhalation with
deep breaths. For the last 6 patients evaluated, RHC
measurements were obtained to calculate PVR at rest and
during exercise using the calculation mean PAP e mean
PCWP/cardiac output. All RHC data were hand measured
and calculated at the time of documentation.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
software (version 5.0). A paired t test was used where
appropriate. Data is reported as mean  standard deviation
(SD). P values of <0.05 were considered statistically
significant.
Results
Twelve consecutive patients with CF referred for lung
transplantation completed the RHC with exercise protocol
Table 1 Patient demographics and characteristics.
Characteristic
Age (years) 28.1  11.0a
Race
Caucasian 12 (100%)
Gender
Male 6 (50%)
Female 6 (50%)
CF mutations
DF508/DF508 6 (50%)
DF508/Other 6 (50%)
Sweat chloride (mEq/L) 113  9a
Body mass index 18.8  2.0a
FVC (Liters) 1.8  0.6a
FVC (% predicted) 43  11a
FEV1 (Liters) 0.9  0.3a
FEV1 (% predicted) 25  7a
6-min walk distance (feet) 1172  140
a Mean  standard deviation. Figure 2 Mean pulmonary artery pressures in mmHg at restcompared to exercise.
Figure 3 Systolic pulmonary artery pressures in mmHg at
rest compared to exercise.
Right heart catheterization in cystic fibrosis 1367during the study period. The patient demographics and
characteristics are outlined in Table 1. Mean age (SD) was
28.1  11.0 (range 15e47) years. Each patient had
advanced lung disease with forced expiratory volume in one
second (FEV1) measurements less than 30% of predicted at
baseline when not acutely ill.
Each patient underwent a TTE within two weeks of the
RHC. The results of the TTE for each patient were limited
due to poor acoustic windows from underlying lung disease.
The TTE identified normal right and left ventricular systolic
function and no right ventricular enlargement or hyper-
trophy. Three patients were found to have a patent fora-
men ovale while one had undergone a previous repair of an
atrial septal defect. Four patients had trivial tricuspid
regurgitation with ventricular septal configuration consis-
tent with a right ventricular pressure less than 1/2 of the
left ventricular pressure.
Central hemodynamics measurements using RHC at rest
and during exercise were successfully performed for each
patient in the cohort without complications and no use of
sedation. The RHC catheter was placed into the right in-
ternal jugular without difficulty, no bleeding complications
occurred, and each patient tolerated exercise during RHC.
Fig. 1 illustrates a patient CF during an RHC with the
catheter in place while exercising on an recumbent sta-
tionary bicycle. Despite TTE not estimating an elevation in
PAP for any patient, a diagnosis of PAH was achieved by RHC
in 75% (9/12) of the patients at rest based on mean
PAP > 25 mmHg. There was a significant increase in mean
PAP resting compared to exercise on the stationary bicycle,
27.8  4.9 (range 22e40) mmHg vs 47.2  5.4 (range 38e56)
mmHg, p < 0.0001 (Fig. 2). Additionally, there was signifi-
cant increases in systolic PAP at rest and with exercise
41.4  6.2 (range 34e55) mmHg vs 67.2  7.0 (range 56e78)
mmHg, p Z 0.0024 (Fig. 3) and diastolic PAP at rest and
with exercise 17.2  6.4 (range 10e32) mmHg vs 29.6  6.4
(range 20e41) mmHg, p Z 0.0025 (Fig. 4).
At rest, PCWP measurements were 9.0  2.4 (range
5e14) mmHg, thus there was no evidence of left heart
failure for the cohort. For the last 6 patients, PVRcalculations during exercise compared to rest found a sig-
nificant increase from 3.15  0.3 (range 3.0e6.7) to
12.8  0.6 (12.2e13.9) Wood Units, p Z 0.0313 (Fig. 5).
Discussion
The manifestation of PAH in CF was first established in the
1960’s [16]. However, research investigating PAP in CF has
used TTE to estimate peak velocity of tricuspid regurgitant
jets, pulmonary flow velocity waves, and transtricuspid
pressure gradients [17e19], rather than directly measuring
PAP by RHC. Using TTE diagnostically, a recent single-center
study estimated the prevalence of PAH in end-stage CF at
63.2% (36/57) with mean PAP of 26 mmHg (range
24e30 mmHg) while supine [17]. Moreover, a caseecontrol
study of 17 adult patients with mild-to-moderate CF without
PH at rest and 10 healthy patients demonstrated that CF
patients with mild-to-moderate lung disease need to be
Figure 4 Diastolic pulmonary artery pressures in mmHg at
rest compared to exercise.
1368 D. Hayes et al.screened for pulmonary vascular disease with elevation of
systolic pulmonary arterial pressure using TTE before and
after maximal cardiopulmonary exercise testing [20].
In patients without CF, Tolle et al [6]. investigated
exercise-induced PAH using radial and pulmonary arterial
catheters and radionuclide ventriculographic scanning, as
opposed to previous studies using indirect measurement by
Doppler TTE. Using direct measurement of central hemo-
dynamics at rest and during maximum cardiopulmonary
exercise, Tolle et al [6]. characterized exercise-induced
PAH with invasive hemodynamics in 78 patients with
exercise-induced PAH in comparison to patients with
resting PAH (nZ 15) and normal controls (nZ 16) [6]. The
investigators found a raw change in the mean PAP of
17.5 mmHg and 18 mmHg for patients with resting PAH and
exercise-induced PAH, respectively [6]. In our small cohort,
there was a similar change in the mean PAP during exercise.
In our study, TTE provided important information
regarding cardiac structure and overall global function, but
it provided no useful data in estimating PAP values.
Although TTE is limited in the assessment of PAH in CF, it
should remain a component of the diagnostic evaluation for
a patient being evaluated for lung transplantation since itFigure 5 Pulmonary vascular resistance in Wood Units at rest
compared to exercise.provides useful data regarding overall cardiac anatomy and
function.
A significant increase in PVR was seen during exercise in
the last 6 patients of our cohort. The normal response to
exercise in PVR is characterized by a decrease which was
observed not only in normal controls but also in the sub-
jects with exercise-induced PAH and resting PAH [6].
Although Tonelli et al [17]. reported 49.1% (28/57) of pa-
tients in their cohort had elevated PVR  3 Wood Units,
data was collected only at rest with no measurements
during exercise. The elevation in PVR during exercise in our
cohort may be confounded by hypoxia observed during the
exercise testing. A trend towards increased PVR from
decreased pulmonary arterial compliance is seen in chronic
hypoxia and thus can potentially impact right ventricular
afterload [21e23]. The importance of this significant
elevation in PVR in this small subgroup of patients with CF
needs further investigation.
Despite misconceptions regarding tolerability of RHC in
patients with CF, especially in advanced stages, this study
clearly shows that this patient population can easily
tolerate RHC with exercise and no sedation. There are
limitations to our study, including the small number of
patients and the retrospective collection of data. We
acknowledged these limitations and attempted to decrease
inclusion bias by including all patients referred during the
study period.
In conclusion, this pilot study demonstrated that central
hemodynamics were safely and effectively measured using
RHC at rest and during exercise in patients with CF.
Furthermore, RHC identified PAH in 75% of in our patients
who did not have evidence on TTE with significant wors-
ening of PAH during exercise. Based on these findings, we
feel that further research using RHC is needed to better
define the spectrum of PAH in the CF population.
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